Treatments FDA Approvals and Clinical Trials Increase Treatment Options for MCL Patients Joshua Brody, MD
Emerging Research ASCO 2019: Lymphoma Expert Discusses Advances in Targeted Therapies Joshua Brody, MD, Rebecca Seago-Coyle
Treatments Access to Effective Hodgkin Lymphoma Care at the Community Level Joshua Brody, MD, Esther Schorr, Andrew Evens, DO, MSc, FACP, Andrew Schorr
Ask the Expert How Are Young Adults with Hodgkin Lymphoma Impacted by Treatment? Joshua Brody, MD, Andrew Evens, DO, MSc, FACP, Andrew Schorr
Living With Hodgkin Lymphoma What Should Hodgkin Lymphoma Patients Know About Survivorship? Joshua Brody, MD, Esther Schorr, Andrew Evens, DO, MSc, FACP, Andrew Schorr
Living With Hodgkin Lymphoma An Expert Addresses Fertility Concerns for Hodgkin Lymphoma Patients Joshua Brody, MD, Andrew Evens, DO, MSc, FACP, Andrew Schorr
Emerging Research Will Hodgkin Lymphoma Patients Benefit From Checkpoint Inhibitors? Joshua Brody, MD, Andrew Evens, DO, MSc, FACP, Andrew Schorr
What Is Hodgkin Lymphoma? What Role Does Genetic Testing Play in Hodgkin Lymphoma Care? Joshua Brody, MD, Andrew Evens, DO, MSc, FACP, Andrew Schorr
Emerging Research Immunotherapy for Hodgkin Lymphoma Joshua Brody, MD, Esther Schorr, Andrew Evens, DO, MSc, FACP, Andrew Schorr
Treatments What Is the Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma Patients? Joshua Brody, MD, Esther Schorr, Andrew Schorr
What Is Hodgkin Lymphoma? Epidemiological Research: What Causes Are Associated With Developing Hodgkin Lymphoma? Joshua Brody, MD, Andrew Evens, DO, MSc, FACP, Andrew Schorr
